Indegene posts Q1 net profit higher by 33% YoY to Rs. 116.4 Cr
Alembic Pharmaceuticals Q1 FY26 revenue up 10%; Net profit up 15%
Gland Pharma Q1 FY26 YoY PAT up by 50% to Rs. 216 Cr
Subscribe To Our Newsletter & Stay Updated
Chasing Consistency: Centralizing operations data is the key to optimizing chemicals plants
Implementing a digital transformation in chemical operations to maximize profitability
The complexity of compliance
The Sprint to the Summit: Unlocking Lab Efficiency through Digital Transformation
The guiding role of fluidized and spouted bed technologies in particle building processes